Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

227 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Breast cancer risk 55+ years after irradiation for an enlarged thymus and its implications for early childhood medical irradiation today.
Adams MJ, Dozier A, Shore RE, Lipshultz SE, Schwartz RG, Constine LS, Pearson TA, Stovall M, Winters P, Fisher SG. Adams MJ, et al. Among authors: shore re. Cancer Epidemiol Biomarkers Prev. 2010 Jan;19(1):48-58. doi: 10.1158/1055-9965.EPI-09-0520. Cancer Epidemiol Biomarkers Prev. 2010. PMID: 20056622 Free PMC article.
Insulin-like growth factor II and colorectal cancer risk in women.
Hunt KJ, Toniolo P, Akhmedkhanov A, Lukanova A, Dechaud H, Rinaldi S, Zeleniuch-Jacquotte A, Shore RE, Riboli E, Kaaks R. Hunt KJ, et al. Among authors: shore re. Cancer Epidemiol Biomarkers Prev. 2002 Sep;11(9):901-5. Cancer Epidemiol Biomarkers Prev. 2002. PMID: 12223436
Dairy products and ovarian cancer: a pooled analysis of 12 cohort studies.
Genkinger JM, Hunter DJ, Spiegelman D, Anderson KE, Arslan A, Beeson WL, Buring JE, Fraser GE, Freudenheim JL, Goldbohm RA, Hankinson SE, Jacobs DR Jr, Koushik A, Lacey JV Jr, Larsson SC, Leitzmann M, McCullough ML, Miller AB, Rodriguez C, Rohan TE, Schouten LJ, Shore R, Smit E, Wolk A, Zhang SM, Smith-Warner SA. Genkinger JM, et al. Cancer Epidemiol Biomarkers Prev. 2006 Feb;15(2):364-72. doi: 10.1158/1055-9965.EPI-05-0484. Cancer Epidemiol Biomarkers Prev. 2006. PMID: 16492930
Polymorphisms in RAD51, XRCC2, and XRCC3 are not related to breast cancer risk.
Brooks J, Shore RE, Zeleniuch-Jacquotte A, Currie D, Afanasyeva Y, Koenig KL, Arslan AA, Toniolo P, Wirgin I. Brooks J, et al. Among authors: shore re. Cancer Epidemiol Biomarkers Prev. 2008 Apr;17(4):1016-9. doi: 10.1158/1055-9965.EPI-08-0065. Cancer Epidemiol Biomarkers Prev. 2008. PMID: 18398049 No abstract available.
Dose to the contralateral breast from radiotherapy and risk of second primary breast cancer in the WECARE study.
Stovall M, Smith SA, Langholz BM, Boice JD Jr, Shore RE, Andersson M, Buchholz TA, Capanu M, Bernstein L, Lynch CF, Malone KE, Anton-Culver H, Haile RW, Rosenstein BS, Reiner AS, Thomas DC, Bernstein JL; Women's Environmental, Cancer, and Radiation Epidemiology Study Collaborative Group. Stovall M, et al. Among authors: shore re. Int J Radiat Oncol Biol Phys. 2008 Nov 15;72(4):1021-30. doi: 10.1016/j.ijrobp.2008.02.040. Epub 2008 Jun 14. Int J Radiat Oncol Biol Phys. 2008. PMID: 18556141 Free PMC article. Clinical Trial.
Postmenopausal levels of endogenous sex hormones and risk of colorectal cancer.
Clendenen TV, Koenig KL, Shore RE, Levitz M, Arslan AA, Zeleniuch-Jacquotte A. Clendenen TV, et al. Among authors: shore re. Cancer Epidemiol Biomarkers Prev. 2009 Jan;18(1):275-81. doi: 10.1158/1055-9965.EPI-08-0777. Cancer Epidemiol Biomarkers Prev. 2009. PMID: 19124509 Free PMC article.
Reproductive factors and risk of contralateral breast cancer by BRCA1 and BRCA2 mutation status: results from the WECARE study.
Poynter JN, Langholz B, Largent J, Mellemkjaer L, Bernstein L, Malone KE, Lynch CF, Borg A, Concannon P, Teraoka SN, Xue S, Diep AT, Törngren T, Begg CB, Capanu M, Haile RW; WECARE Study Collaborative Group; Bernstein JL. Poynter JN, et al. Cancer Causes Control. 2010 Jun;21(6):839-46. doi: 10.1007/s10552-010-9510-0. Epub 2010 Feb 4. Cancer Causes Control. 2010. PMID: 20130978 Free PMC article.
Adjuvant systemic therapy for breast cancer in BRCA1/BRCA2 mutation carriers in a population-based study of risk of contralateral breast cancer.
Reding KW, Bernstein JL, Langholz BM, Bernstein L, Haile RW, Begg CB, Lynch CF, Concannon P, Borg A, Teraoka SN, Törngren T, Diep A, Xue S, Bertelsen L, Liang X, Reiner AS, Capanu M, Malone KE; WECARE Collaborative Study Group. Reding KW, et al. Breast Cancer Res Treat. 2010 Sep;123(2):491-8. doi: 10.1007/s10549-010-0769-3. Epub 2010 Feb 5. Breast Cancer Res Treat. 2010. PMID: 20135344 Free PMC article.
227 results